{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:16:21Z","timestamp":1794280581228,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Cardiovascular disease (CVD) is the leading cause of death after treatment for endometrial cancer (EC). There is clinical evidence that exercise significantly reduces the risks of CVD and cancer recurrence in this population; however, it is unclear whether there is value for money in integrating exercise into cancer recovery care for women treated for EC. This paper assesses the long-term cost-effectiveness of a 12-week supervised exercise intervention, as compared with standard care, for women diagnosed with early-stage EC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>A cost-utility analysis was conducted from the Australian health system perspective for a time horizon of 5 years. A Markov cohort model was designed with six mutually exclusive health states: (i) no CVD, (ii) post-stroke, (iii) post-coronary heart disease (CHD), (iv) post-heart failure, (v) post-cancer recurrence, and (vi) death. The model was populated using the best available evidence. Costs and quality-adjusted life years (QALYs) were discounted at 5% annual rate. Uncertainty in the results was explored using one-way and probabilistic sensitivity analyses (PSA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>The incremental cost of supervised exercise versus standard care was AUD $358, and the incremental QALY was 0.0789, resulting in an incremental cost-effectiveness ratio (ICER) of AUD $5184 per QALY gained. The likelihood that the supervised exercise intervention was cost-effective at a willingness-to-pay threshold of AUD $50,000 per QALY was 99.5%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first economic evaluation of exercise after treatment for EC. The results suggest that exercise is cost-effective for Australian EC survivors. Given the compelling evidence, efforts could now focus on the implementation of exercise as part of cancer recovery care in Australia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-023-07819-y","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T06:02:41Z","timestamp":1686636161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-utility analysis of a supervised exercise intervention for women with early-stage endometrial cancer"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-2465","authenticated-orcid":false,"given":"Yufan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Tuffaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"issue":"10023","key":"7819_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P et al (2016) Endometrial cancer. Lancet 387(10023):1094\u20131108","journal-title":"Lancet"},{"issue":"9","key":"7819_CR2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","volume":"33","author":"A Oaknin","year":"2022","unstructured":"Oaknin A et al (2022) Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2606. Ann Oncol 33(9):860\u2013877","journal-title":"Ann Oncol"},{"issue":"11","key":"7819_CR3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L et al (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921","journal-title":"Cancer Res"},{"key":"7819_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijgo.12612","volume":"143","author":"F Amant","year":"2018","unstructured":"Amant F et al (2018) Cancer of the corpus uteri. Int J Gynecol Obstet 143:37\u201350","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"7819_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/nutrit\/nuu063","volume":"73","author":"DA Koutoukidis","year":"2015","unstructured":"Koutoukidis DA, Knobf MT, Lanceley A (2015) Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev 73(6):399\u2013408","journal-title":"Nutr Rev"},{"key":"7819_CR6","doi-asserted-by":"publisher","unstructured":"Fader AN, Frasure HE, Gil KM, Berger NA, von Gruenigen VE (2011) Quality of life in endometrial cancer survivors: what does obesity have to do with it? Obstet Gynecol Int 2011:6.\u00a0https:\/\/doi.org\/10.1155\/2011\/308609","DOI":"10.1155\/2011\/308609"},{"issue":"12","key":"7819_CR7","first-page":"1342","volume":"110","author":"S Soisson","year":"2018","unstructured":"Soisson S et al (2018) Long-term cardiovascular outcomes among endometrial cancer survivors in a large, population-based cohort study. JNCI: Journal of the National Cancer Institute 110(12):1342\u20131351","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"3","key":"7819_CR8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ygyno.2015.07.004","volume":"138","author":"KC Kurnit","year":"2015","unstructured":"Kurnit KC et al (2015) Increased prevalence of comorbid conditions in women with uterine cancer. Gynecol Oncol 138(3):731\u2013734","journal-title":"Gynecol Oncol"},{"issue":"2","key":"7819_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2012.04.013","volume":"126","author":"KK Ward","year":"2012","unstructured":"Ward KK et al (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126(2):176\u2013179","journal-title":"Gynecol Oncol"},{"issue":"10","key":"7819_CR10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10552-017-0953-4","volume":"28","author":"AS Felix","year":"2017","unstructured":"Felix AS et al (2017) Cardiovascular disease mortality among women with endometrial cancer in the Iowa women\u2019s health study. Cancer Causes Control 28(10):1043\u20131051","journal-title":"Cancer Causes Control"},{"issue":"1","key":"7819_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-019-1154-5","volume":"17","author":"MC Robertson","year":"2019","unstructured":"Robertson MC et al (2019) Change in physical activity and quality of life in endometrial cancer survivors receiving a physical activity intervention. Health Qual Life Outcomes 17(1):1\u20139","journal-title":"Health Qual Life Outcomes"},{"issue":"34","key":"7819_CR12","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1200\/JCO.20.01336","volume":"38","author":"CM Friedenreich","year":"2020","unstructured":"Friedenreich CM et al (2020) Prospective cohort study of pre-and postdiagnosis physical activity and endometrial cancer survival. J Clin Oncol 38(34):4107","journal-title":"J Clin Oncol"},{"issue":"2","key":"7819_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3802\/jgo.2015.26.2.141","volume":"26","author":"A Rossi","year":"2015","unstructured":"Rossi A et al (2015) Physical activity for an ethnically diverse sample of endometrial cancer survivors: a needs assessment and pilot intervention. J Gynecol Oncol 26(2):141\u2013147","journal-title":"J Gynecol Oncol"},{"issue":"13","key":"7819_CR14","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3390\/cancers14133096","volume":"14","author":"D Weikart","year":"2022","unstructured":"Weikart D et al (2022) Pre-diagnosis diet and physical activity and risk of cardiovascular disease mortality among female cancer survivors. Cancers 14(13):3096","journal-title":"Cancers"},{"key":"7819_CR15","doi-asserted-by":"crossref","first-page":"153473542091746","DOI":"10.1177\/1534735420917462","volume":"19","author":"S Morishita","year":"2020","unstructured":"Morishita S et al (2020) Effect of exercise on mortality and recurrence in patients with cancer: a systematic review and meta-analysis. Integrative cancer therapies 19:1534735420917462","journal-title":"Integrative cancer therapies"},{"issue":"4","key":"7819_CR16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja18.00199","volume":"209","author":"P Cormie","year":"2018","unstructured":"Cormie P et al (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 209(4):184\u2013187","journal-title":"Med J Aust"},{"issue":"11","key":"7819_CR17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jsams.2019.05.003","volume":"22","author":"SC Hayes","year":"2019","unstructured":"Hayes SC et al (2019) The Exercise and Sports Science Australia position statement: exercise medicine in cancer management. J Sci Med Sport 22(11):1175\u20131199","journal-title":"J Sci Med Sport"},{"key":"7819_CR18","doi-asserted-by":"crossref","unstructured":"Wang Y et al (2023) Economic evaluation of exercise interventions for individuals with cancer: A systematic review. Prev Med:107491","DOI":"10.1016\/j.ypmed.2023.107491"},{"issue":"22","key":"7819_CR19","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1200\/JCO.2017.77.5809","volume":"36","author":"JM Scott","year":"2018","unstructured":"Scott JM et al (2018) Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol 36(22):2297","journal-title":"J Clin Oncol"},{"issue":"1","key":"7819_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","volume":"25","author":"D Husereau","year":"2022","unstructured":"Husereau D et al (2022) Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II Good Practices Task Force. Value Health 25(1):10\u201331","journal-title":"Value Health"},{"issue":"20","key":"7819_CR21","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31(20):2607","journal-title":"J Clin Oncol"},{"issue":"1","key":"7819_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07882-8","volume":"10","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG et al (2019) Stroke among cancer patients. Nat Commun 10(1):1\u20138","journal-title":"Nat Commun"},{"issue":"1","key":"7819_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15639-5","volume":"11","author":"KC Stoltzfus","year":"2020","unstructured":"Stoltzfus KC et al (2020) Fatal heart disease among cancer patients. Nat Commun 11(1):1\u20138","journal-title":"Nat Commun"},{"issue":"11","key":"7819_CR24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5694\/mja2.51085","volume":"214","author":"B Nadlacki","year":"2021","unstructured":"Nadlacki B et al (2021) Long term survival after acute myocardial infarction in Australia and New Zealand, 2009\u20132015: a population cohort study. Med J Aust 214(11):519\u2013525","journal-title":"Med J Aust"},{"key":"7819_CR25","doi-asserted-by":"publisher","unstructured":"Hariharaputhiran S, Peng Y, Ngo L, Ali A, Hossain S, Visvanathan R et al (2022) Long-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand. Eur J Heart Fail\u00a024(9):1519\u20131528. https:\/\/doi.org\/10.1002\/ejhf.2595","DOI":"10.1002\/ejhf.2595"},{"issue":"8","key":"7819_CR26","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/STROKEAHA.121.038155","volume":"53","author":"Y Peng","year":"2022","unstructured":"Peng Y et al (2022) Long-term survival, stroke recurrence, and life expectancy after an acute stroke in Australia and New Zealand from 2008-2017: a population-wide cohort study. Stroke 53(8):2538\u20132548","journal-title":"Stroke"},{"issue":"1","key":"7819_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinthera.2010.01.009","volume":"32","author":"Z Ademi","year":"2010","unstructured":"Ademi Z et al (2010) The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin Ther 32(1):119\u2013132","journal-title":"Clin Ther"},{"issue":"2","key":"7819_CR28","first-page":"829","volume":"34","author":"T Hildebrandt","year":"2014","unstructured":"Hildebrandt T et al (2014) Health utilities in gynecological oncology and mastology in Germany. Anticancer Res 34(2):829\u2013835","journal-title":"Anticancer Res"},{"issue":"1","key":"7819_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-015-0772-9","volume":"15","author":"LS Matza","year":"2015","unstructured":"Matza LS et al (2015) Acute and chronic impact of cardiovascular events on health state utilities. BMC Health Serv Res 15(1):1\u201311","journal-title":"BMC Health Serv Res"},{"issue":"23","key":"7819_CR30","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1200\/JCO.2015.65.6603","volume":"34","author":"LW Jones","year":"2016","unstructured":"Jones LW et al (2016) Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol 34(23):2743","journal-title":"J Clin Oncol"},{"issue":"3","key":"7819_CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12325-016-0471-x","volume":"34","author":"A Griffiths","year":"2017","unstructured":"Griffiths A et al (2017) Analyzing health-related quality of life data to estimate parameters for cost-effectiveness models: an example using longitudinal EQ-5D data from the SHIFT randomized controlled trial. Adv Ther 34(3):753\u2013764","journal-title":"Adv Ther"},{"issue":"7","key":"7819_CR32","doi-asserted-by":"crossref","first-page":"e0201552","DOI":"10.1371\/journal.pone.0201552","volume":"13","author":"DE Goldsbury","year":"2018","unstructured":"Goldsbury DE et al (2018) Health services costs for cancer care in Australia: estimates from the 45 and Up Study. PLoS One 13(7):e0201552","journal-title":"PLoS One"},{"issue":"1","key":"7819_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-020-01407-y","volume":"18","author":"MB Betts","year":"2020","unstructured":"Betts MB et al (2020) Utility value estimates in cardiovascular disease and the effect of changing elicitation methods: a systematic literature review. Health Qual Life Outcomes 18(1):1\u201312","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"7819_CR34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/2047487320938272","volume":"28","author":"F Savira","year":"2020","unstructured":"Savira F et al (2020) Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspective. Eur J Prev Cardiol 28(9):975\u2013982","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"7819_CR35","doi-asserted-by":"crossref","first-page":"e053305","DOI":"10.1136\/bmjopen-2021-053305","volume":"11","author":"P Lee","year":"2021","unstructured":"Lee P et al (2021) Estimating the economic impacts of percutaneous coronary intervention in Australia: a registry-based cost burden study. BMJ Open 11(12):e053305","journal-title":"BMJ Open"},{"issue":"8","key":"7819_CR36","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/eurjpc\/zwab001","volume":"29","author":"C Marquina","year":"2021","unstructured":"Marquina C et al (2021) Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029. Eur J Prev Cardiol 29(8):1212\u20131219","journal-title":"Eur J Prev Cardiol"},{"key":"7819_CR37","doi-asserted-by":"crossref","unstructured":"Sanjida S et al (2021) Long-term quality of life outcomes of women treated for early-stage endometrial cancer. International Journal of Gynecologic. Cancer 31(4)","DOI":"10.1136\/ijgc-2020-002145"},{"key":"7819_CR38","unstructured":"Australian Bureau of Statistics (2021) Life tables. [Internet]; Available from: https:\/\/www.abs.gov.au\/statistics\/people\/population\/life-tables\/latest-release"},{"issue":"4","key":"7819_CR39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/joa3.12586","volume":"37","author":"V Thijs","year":"2021","unstructured":"Thijs V et al (2021) Cost-effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia. Journal of arrhythmia 37(4):1077\u20131085","journal-title":"Journal of arrhythmia"},{"issue":"1","key":"7819_CR40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/CCM.0000000000005118","volume":"50","author":"GM Pound","year":"2022","unstructured":"Pound GM et al (2022) Long-term functional outcome and quality of life following in-hospital cardiac arrest\u2014a longitudinal cohort study. Crit Care Med 50(1):61\u201371","journal-title":"Crit Care Med"},{"key":"7819_CR41","unstructured":"American Cancer Society (2022) Survival Rates for Endometrial Cancer. [Internet]; Available from: https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"issue":"34","key":"7819_CR42","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1200\/JCO.20.01336","volume":"38","author":"CM Friedenreich","year":"2020","unstructured":"Friedenreich CM et al (2020) Prospective cohort study of pre- and postdiagnosis physical activity and endometrial cancer survival. J Clin Oncol 38(34):4107\u20134117","journal-title":"J Clin Oncol"},{"issue":"11","key":"7819_CR43","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-020-00937-z","volume":"38","author":"R Gidwani","year":"2020","unstructured":"Gidwani R, Russell LB (2020) Estimating transition probabilities from published evidence: a tutorial for decision modelers. Pharmacoeconomics 38(11):1153\u20131164","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"7819_CR44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1055-9965.EPI-18-0264","volume":"27","author":"AS Felix","year":"2018","unstructured":"Felix AS, Brinton LA (2018) Cancer progress and priorities: uterine cancer. Cancer Epidemiol Biomark Prev 27(9):985\u2013994","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"7819_CR45","doi-asserted-by":"crossref","first-page":"888","DOI":"10.6004\/jnccn.2021.0038","volume":"19","author":"NR Abu-Rustum","year":"2021","unstructured":"Abu-Rustum NR et al (2021) NCCN Guidelines\u00ae Insights: uterine neoplasms, Version 3.2021: Featured Updates to the NCCN Guidelines. J Natl Compr Cancer Netw 19(8):888\u2013895","journal-title":"J Natl Compr Cancer Netw"},{"key":"7819_CR46","doi-asserted-by":"crossref","unstructured":"Khan KA, Mazuquin B, Canaway A, Petrou S, Bruce J (2019) Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer. Breast Cancer Res Treat 176:37\u201352.","DOI":"10.1007\/s10549-019-05235-7"},{"issue":"6","key":"7819_CR47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11764-021-01002-0","volume":"15","author":"BE Gubler-Gut","year":"2021","unstructured":"Gubler-Gut BE et al (2021) Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review. J Cancer Surviv 15(6):961\u2013975","journal-title":"J Cancer Surviv"},{"issue":"12","key":"7819_CR48","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1634\/theoncologist.2012-0151","volume":"17","author":"JC Mewes","year":"2012","unstructured":"Mewes JC et al (2012) Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review. Oncologist 17(12):1581","journal-title":"Oncologist"},{"issue":"2","key":"7819_CR49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-005-5828-9","volume":"94","author":"LG Gordon","year":"2005","unstructured":"Gordon LG et al (2005) A cost-effectiveness analysis of two rehabilitation support services for women with breast cancer. Breast Cancer Res Treat 94(2):123\u2013133","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7819_CR50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11764-014-0396-9","volume":"9","author":"JC Mewes","year":"2015","unstructured":"Mewes JC et al (2015) Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv 9(1):126\u2013135","journal-title":"J Cancer Surviv"},{"key":"7819_CR51","doi-asserted-by":"publisher","unstructured":"Gao L et al (2017) Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation. Clin Transpl 31(9).\u00a0https:\/\/doi.org\/10.1111\/ctr.13049","DOI":"10.1111\/ctr.13049"},{"key":"7819_CR52","doi-asserted-by":"crossref","unstructured":"Gordon LG et al (2020) Cost-effectiveness analysis from a randomized controlled trial of tailored exercise prescription for women with breast cancer with 8-year follow-up. Int J Environ Res Public Health 17(22)","DOI":"10.3390\/ijerph17228608"},{"issue":"3","key":"7819_CR53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/PHM.0000000000001281","volume":"99","author":"D Ha","year":"2020","unstructured":"Ha D et al (2020) A model-based cost-effectiveness analysis of an exercise program for lung cancer survivors after curative-intent treatment. Am J Phys Med Rehabil 99(3):233\u2013240","journal-title":"Am J Phys Med Rehabil"},{"key":"7819_CR54","doi-asserted-by":"crossref","unstructured":"Edmunds K et al (2022) Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis. Support Care Cancer:1\u201310","DOI":"10.1007\/s00520-022-06900-2"},{"issue":"1","key":"7819_CR55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2017.07.005","volume":"21","author":"VS Gc","year":"2018","unstructured":"Gc VS et al (2018) Cost-Effectiveness and value of information analysis of brief interventions to promote physical activity in primary care. Value Health 21(1):18\u201326","journal-title":"Value Health"},{"key":"7819_CR56","unstructured":"Cancer Australia (2022) Uterine cancer statistics. [Internet]; Available from: https:\/\/www.canceraustralia.gov.au\/cancer-types\/uterine-cancer\/statistics"},{"issue":"7","key":"7819_CR57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hec.1093","volume":"15","author":"MJ Sculpher","year":"2006","unstructured":"Sculpher MJ et al (2006) Whither trial-based economic evaluation for health care decision making? Health Econ 15(7):677\u2013687","journal-title":"Health Econ"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07819-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07819-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:07:57Z","timestamp":1689329277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07819-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7819"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07819-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"391"}}